Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04059640Not ApplicableActive Not Recruiting

PMCF Study of LiquiBand FIX8® OHMF Device

Role: collaborator

NCT04621825Not ApplicableCompleted

Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam

Role: collaborator

NCT04341298Not ApplicableCompleted

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

Role: collaborator

NCT01731860Not ApplicableCompleted

Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector

Role: collaborator

All 4 trials loaded